Acupuncture May Reduce Itching in Atopic Dermatitis: Study Dr Riya Dave25 Feb 2026 10:00 PM ISTAcupuncture can relieve itch in patients with atopic dermatitis (AD), but it does not improve the severity of the disease significantly, as per the...
Rezpegaldesleukin Shows Sustained Benefit in Moderate-to-Severe Atopic Dermatitis in Phase 2 b trial Dr. Kamal Kant Kohli22 Feb 2026 8:15 PM ISTThe phase 2b REZOLVE-AD trial enrolled 393 adults with moderate-to-severe atopic dermatitis across approximately 110 global sites, randomizing them to...
No Overall Association Between Atopic Dermatitis and Contact Sensitization,suggests study Dr. Shravani Dali20 Feb 2026 8:30 PM ISTResearchers have found in a new study that there is no general association between atopic dermatitis (AD) and contact sensitization (CS). However,...
New tyrosine kinase 2 inhibitor shows Promising Safety and Efficacy in Atopic Dermatitis: JAMA Jacinthlyn Sylvia17 Feb 2026 9:00 PM ISTA new study published in the Journal of the American Medical Association showed that in the treatment of atopic dermatitis (AD), once-daily oral...
Aurobindo Arm Acrotech Secures USFDA Nod for Atopic Dermatitis Drug ADQUEY Susmita Roy16 Feb 2026 5:00 PM ISTNew Delhi: Aurobindo Pharma Limited announced that its wholly owned step-down subsidiary, Acrotech Biopharma, has received approval from the U.S. Food...
Dupilumab Highly Effective in Refractory Atopic Dermatitis: Study Jacinthlyn Sylvia5 Feb 2026 8:30 PM ISTA new study published in the journal of Pediatric Dermatology revealed that treatment with dupilumab achieved effective disease control in 87.8% of...
Large-scale genetic study sheds light on the background of allergic conjunctivitis Dr. Kamal Kant Kohli2 Feb 2026 10:00 PM ISTItchy, red and watery eyes are familiar symptoms for many people, especially during the spring and summer pollen season. Allergic conjunctivitis is a...
Nemolizumab Rapidly Improves Itch and Sleep in Atopic Dermatitis and Prurigo Nodularis: Study Jacinthlyn Sylvia2 Feb 2026 8:30 PM ISTA new study published in the Journal of the European Academy of Dermatology and Venerology showed that nemolizumab, an interleukin-31 pathway...
PROMIS Measures effective tools for Assessing Impact of Chronic Skin Diseases: JAMA Dr Riya Dave29 Jan 2026 9:00 PM ISTA recent study published in JAMA Dermatology has demonstrated that PROMIS measures are valid tools for evaluating the physical, emotional, and social...
Tralokinumab Shows Sustained Efficacy in Hand Atopic Dermatitis: Study Dr. Kamal Kant Kohli27 Jan 2026 9:45 PM ISTThe ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic...
Amlitelimab Shows Promise in Moderate-to-Severe Atopic Dermatitis in Phase 3 trial Dr. Kamal Kant Kohli24 Jan 2026 8:00 AM ISTAmlitelimab, an OX40 ligand-targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, demonstrated clinical...
